Vol. 22 No. 1 (2024)

Articles

• Natural- and in vitro-grown Filipendula ulmaria (L.) Maxim: evaluation of pharmaceutical potential (antibacterial, antioxidant and toxicity) and phenolic profiles

  Arzu Birinci Yildirim, Ayca Cimen, Yavuz Baba, Arzu Turker

  1-10

  • PDF

• The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health

  Adam Piasecki, Magdalena Sitnik, Jakub Olszewski, Maciej Bara, Katarzyna Herjan, Piotr Armański

  11-15

  • PDF

• SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases

  Mateusz Sobczyk, Daria Żuraw, Paulina Oleksa, Kacper Jasiński, Mikołaj Porzak, Michał Dacka

  16-22

  • PDF

• A financial perspective on the pharmaceutical industry

  Yunus Emre Kahraman, Yılmaz Çalışkan

  23-31

  • PDF

• Exploring digital health horizons: a narrative review of e-health innovations in Poland, Spain, Romania and Estonia.

  Aleksandra Białczyk, Gabriela Leśniak, Filip Nadolny, Justyna Mrowiec, Antoni Otałęga

  32-37

  • PDF